Drugs Made In America Acquisition Ownership | Who Owns Drugs Made In America Acquisition?


OverviewFinancialsChart

Drugs Made In America Acquisition Ownership Summary


Drugs Made In America Acquisition is owned by 216620.31% institutional investors, 26.77% insiders. Wolverine asset management is the largest institutional shareholder, holding 3.73% of DMAA shares.

DMAA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDrugs Made In America Acquisition216620.31%26.77%-216547.08%
IndustryShell Companies Stocks 7216.93%22.41%-7139.34%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wolverine asset management1.25M3.73%$12.83M
Mizuho securities usa1.10M3.28%$11.29M
Atw spac management500.00K1.49%$5.13B
Context capital management250.00K0.75%$2.57B
Dld asset management, lp113.67K0.34%$1.17B
Jpmorgan chase99.69K0.30%$1.02M
Warberg asset management92.06K0.27%$945.40M
Geode capital management45.65K0.14%$468.80K
Dakota wealth management36.40K0.11%$373.83K
Quarry lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Atw spac management500.00K6.48%$5.13B
Mizuho securities usa1.10M0.23%$11.29M
Warberg asset management92.06K0.15%$945.40M
Wolverine asset management1.25M0.09%$12.83M
Dld asset management, lp113.67K0.08%$1.17B
Context capital management250.00K0.08%$2.57B
Dakota wealth management36.40K0.01%$373.83K
Jpmorgan chase99.69K0.00%$1.02M
Quarry lp---
Geode capital management45.65K-$468.80K

Top Buyers

HolderShares% AssetsChange
Context capital management250.00K0.08%250.00K
Wolverine asset management1.25M0.09%227.22K
Mizuho securities usa1.10M0.23%180.66K
Jpmorgan chase99.69K0.00%99.69K
Dakota wealth management36.40K0.01%36.40K

Top Sellers

HolderShares% AssetsChange
Quarry lp---650.00K
Dld asset management, lp113.67K0.08%-75.05K
Atw spac management500.00K6.48%-70.00K
Geode capital management45.65K--
Warberg asset management92.06K0.15%-

New Positions

HolderShares% AssetsChangeValue
Context capital management250.00K0.08%250.00K$2.57B
Jpmorgan chase99.69K0.00%99.69K$1.02M
Dakota wealth management36.40K0.01%36.40K$373.83K

Sold Out

HolderChange
Quarry lp-650.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20253233.33%20,823,19510.54%216,6200.00%18-21.74%6-
Mar 31, 202525-19,688,102-229,706-24---

Recent Insider Transactions


DateNameRoleActivityValue
Feb 18, 2025Drugs Made In America Acquisition LLC-Buy-
Feb 18, 2025Drugs Made In America Acquisition LLC-Buy-
Feb 18, 2025Stockwell Lynn CEO and Exe. Chair of BoardBuy-
Feb 18, 2025Stockwell Lynn CEO and Exe. Chair of BoardBuy-
Jan 29, 2025Drugs Made In America Acquisition LLC-Buy-

Insider Transactions Trends


DateBuySell
2025 Q182

DMAA Ownership FAQ


Who Owns Drugs Made In America Acquisition?

Drugs Made In America Acquisition shareholders are primarily institutional investors at 216620.31%, followed by 26.77% insiders and -216547.08% retail investors. The average institutional ownership in Drugs Made In America Acquisition's industry, Shell Companies Stocks , is 7216.93%, which Drugs Made In America Acquisition exceeds.

Who owns the most shares of Drugs Made In America Acquisition?

Drugs Made In America Acquisition’s largest shareholders are Wolverine asset management (1.25M shares, 3.73%), Mizuho securities usa (1.1M shares, 3.28%), and Atw spac management (500K shares, 1.49%). Together, they hold 8.50% of Drugs Made In America Acquisition’s total shares outstanding.

Does Blackrock own Drugs Made In America Acquisition?

BlackRock is not among the top 10 institutional shareholders of Drugs Made In America Acquisition.

Who is Drugs Made In America Acquisition’s biggest shareholder by percentage of total assets invested?

Atw spac management is Drugs Made In America Acquisition’s biggest shareholder by percentage of total assets invested, with 6.48% of its assets in 500K Drugs Made In America Acquisition shares, valued at 5.14B$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools